Literature DB >> 15882984

Purification of infectious adenovirus in two hours by ultracentrifugation and tangential flow filtration.

Hideyo Ugai1, Takahito Yamasaki, Megumi Hirose, Kumiko Inabe, Yukari Kujime, Miho Terashima, Bingbing Liu, Hong Tang, Mujun Zhao, Takehide Murata, Makoto Kimura, Jianzhi Pan, Yuichi Obata, Hirofumi Hamada, Kazunari K Yokoyama.   

Abstract

Adenoviruses are excellent vectors for gene transfer and are used extensively for high-level expression of the products of transgenes in living cells. The development of simple and rapid methods for the purification of stable infectious recombinant adenoviruses (rAds) remains a challenge. We report here a method for the purification of infectious adenovirus type 5 (Ad5) that involves ultracentrifugation on a cesium chloride gradient at 604,000g for 15 min at 4 degrees C and tangential flow filtration. The entire procedure requires less than two hours and infectious Ad5 can be recovered at levels higher than 64% of the number of plaque-forming units (pfu) in the initial crude preparation of viruses. We have obtained titers of infectious purified Ad5 of 1.35x10(10) pfu/ml and a ratio of particle titer to infectious titer of seven. The method described here allows the rapid purification of rAds for studies of gene function in vivo and in vitro, as well as the rapid purification of Ad5.

Entities:  

Mesh:

Year:  2005        PMID: 15882984     DOI: 10.1016/j.bbrc.2005.03.227

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Thermostability/infectivity defect caused by deletion of the core protein V gene in human adenovirus type 5 is rescued by thermo-selectable mutations in the core protein X precursor.

Authors:  Hideyo Ugai; Anton V Borovjagin; Long P Le; Minghui Wang; David T Curiel
Journal:  J Mol Biol       Date:  2006-12-06       Impact factor: 5.469

Review 2.  Vaccine development for human mastadenovirus.

Authors:  Shiying Chen; Xingui Tian
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

3.  Adenoviral protein V promotes a process of viral assembly through nucleophosmin 1.

Authors:  Hideyo Ugai; George C Dobbins; Minghui Wang; Long P Le; David A Matthews; David T Curiel
Journal:  Virology       Date:  2012-06-18       Impact factor: 3.616

4.  JDP2 (Jun Dimerization Protein 2)-deficient mouse embryonic fibroblasts are resistant to replicative senescence.

Authors:  Koji Nakade; Jianzhi Pan; Takahito Yamasaki; Takehide Murata; Bohdan Wasylyk; Kazunari K Yokoyama
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

5.  Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5.

Authors:  Shinya Abe; Kenji Okuda; Takehiro Ura; Asami Kondo; Atsushi Yoshida; Shinji Yoshizaki; Hiroyuki Mizuguchi; Dennis Klinman; Masaru Shimada
Journal:  J Gene Med       Date:  2009-07       Impact factor: 4.565

6.  In vitro dynamic visualization analysis of fluorescently labeled minor capsid protein IX and core protein V by simultaneous detection.

Authors:  Hideyo Ugai; Minghui Wang; Long P Le; David A Matthews; Masato Yamamoto; David T Curiel
Journal:  J Mol Biol       Date:  2009-10-21       Impact factor: 5.469

7.  A Multi Targeting Conditionally Replicating Adenovirus Displays Enhanced Oncolysis while Maintaining Expression of Immunotherapeutic Agents.

Authors:  G Clement Dobbins; Hideyo Ugai; David T Curiel; G Yancey Gillespie
Journal:  PLoS One       Date:  2015-12-21       Impact factor: 3.240

8.  Purification of Bionanoparticles.

Authors:  L Pedro; S S Soares; G N M Ferreira
Journal:  Chem Eng Technol       Date:  2008-05-27       Impact factor: 1.728

9.  Periostin is essential for cardiac healing after acute myocardial infarction.

Authors:  Masashi Shimazaki; Kazuto Nakamura; Isao Kii; Takeshi Kashima; Norio Amizuka; Minqi Li; Mitsuru Saito; Keiichi Fukuda; Takashi Nishiyama; Satoshi Kitajima; Yumiko Saga; Masashi Fukayama; Masataka Sata; Akira Kudo
Journal:  J Exp Med       Date:  2008-01-21       Impact factor: 14.307

10.  Analysis of purified wild type and mutant adenovirus particles by SILAC based quantitative proteomics.

Authors:  Ali Alqahtani; Kate Heesom; Jonathan L Bramson; David Curiel; Hideyo Ugai; David A Matthews
Journal:  J Gen Virol       Date:  2014-08-05       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.